Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/fluticasone propionate versus ipratropium/albuterol in Chinese patients with moderate-to-severe COPD
ChiCTR-TRC-10001088Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic obstructive pulmonary disease (COPD) comparing Salmeterol/fluticasone propionate with Ipratropium/albuterol (2 arms). Primary endpoint: Pre-bronchodilator FEV1. Started Sep 2008; status: completed.
02
Drugs
salmeterolfluticasone propionateipratropium bromidesalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-10001088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001088.